Tareq Abadl/LinkedIn
Sep 4, 2026, 18:22
Tareq Abadl: The Clinical Meaning of C3 and C4
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
”Complement C3 vs C4 — Don’t Mix Them Up!
Confused about C3 vs C4 in Immunology?
Here’s the high-yield difference you need to remember:
- C3 is the major and central complement component.
- C4 is mainly associated with the Classical and Lectin pathways.
Clinical Pearl:
- Low C3 with normal C4 may suggest alternative pathway activation.
- Low C3 with low C4 may indicate classical pathway consumption.
ASCP / BOC Pearl:
- Don’t interpret complement levels alone.
- Always correlate C3, C4, and clinical findings.”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 13:36Shobhna Ladva: Aspen Pharma EME Raises Awareness of Blood Clot Risks During Hormonal Transitions
-
Oct 19, 2026, 13:11Giulia Furnari: Connecting With Global Hematology Experts at IACH 2026
-
Oct 19, 2026, 12:46Andrew Choong: Recognizing Thrombosis Before It Becomes Life-Threatening
-
Oct 19, 2026, 11:37Beth Faiman: APSHO Fellows Celebrated for Advancing Hematology and Oncology Practice
-
Oct 19, 2026, 11:26Emanuele Pacini: Myelodysplastic Syndromes Research Featured at JSH Annual Meeting in Kyoto
-
Oct 19, 2026, 10:57Jesmond Dalli: How Erythroblasts Shape Neutrophil Development and Function
-
Oct 19, 2026, 10:41Hisham Fahmi: SCD – Should Gene Editing Begin Before Organ Damage?
-
Oct 19, 2026, 10:33Pallavi Madhiraju: YARTEMLEA Faces Another European Rejection Despite FDA Approval
-
Oct 19, 2026, 10:28Brig Tathagata Chatterjee: Acute Leukemias in AYAs at the Japanese Society of Hematology Conference